BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
306 results:

  • 1. Serum sodium level fluctuations following the resection of childhood-onset craniopharyngioma.
    Miao Y; Fan K; Peng X; Li S; Chen J; Wei Y; Deng Y; Zhao C; Wu Q; Ge M; Gong J; Wu D
    Brain Behav; 2024 Mar; 14(3):e3430. PubMed ID: 38433103
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identify novel inflammation-related prognostic signature in pancreatic cancer patients.
    Sun Y; Zhang X; Zhu H
    Medicine (Baltimore); 2024 Feb; 103(7):e36932. PubMed ID: 38363947
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KIF20B and met, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
    Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
    Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
    Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
    Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Serum Lipid Level in Evaluating Chinese Pancreatic Neuroendocrine Neoplasms: A Retrospective Study.
    Gu D; Xue B; Zhu G; Xu Y; Yan L; Tang Q; Lu C
    Exp Clin Endocrinol Diabetes; 2024 Feb; 132(2):98-106. PubMed ID: 38096919
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
    Shen H; Pang Q; Gao Y; Liu H
    BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
    Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
    Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [The thyroid cancer in children and adolescents: about 22 cases].
    Anajar S; Tatari MM; Lakhbal A; Abada R; Rouadi S; Roubal M; Mahtar M
    Pan Afr Med J; 2023; 46():9. PubMed ID: 37928225
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. High expression ITGA2 affects the expression of met, PD-L1, CD4 and CD8 with the immune microenvironment in pancreatic cancer patients.
    Jin L; Duan Y; Li X; Li Z; Hu J; Shi H; Su Z; Li Z; Du B; Chen Y; Tan Y
    Front Immunol; 2023; 14():1209367. PubMed ID: 37881431
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid cancer.
    Xie W; Li H; Lin Q; Ke N
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological and prognostic values of met expression in pancreatic adenocarcinoma based on bioinformatics analysis.
    Yao Y; Zhan R; Gong C; Lv J; Lu X
    Medicine (Baltimore); 2023 Oct; 102(41):e34656. PubMed ID: 37832054
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer.
    Zhang B; Chen X; Wang Z; Guo F; Zhang X; Huang B; Ma S; Xia S; Shang D
    Aging (Albany NY); 2023 Oct; 15(19):10549-10579. PubMed ID: 37815881
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Prospective Multicenter Study Examining the Relationship Between Thyroid cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
    De Leo S; D'Elia S; Grani G; Dondi F; Bertagna F; Puxeddu E; Morelli S; Piovesan A; Nervo A; Zatelli MC; Gagliardi I; Samà MT; Aimaretti G; Crocetti U; Massa M; Deandrea M; Retta F; Pagano L; Rossi M; Solaroli E; Pezzullo L; Chiofalo MG; Pontecorvi A; Lombardi CP; Antonelli A; Patrizio A; Messuti I; Magri F; Spiazzi G; Ceresini G; Bruno R; Sparano C; Centanni M; Crescenzi A; Tallini G; Marotta V; Madeo B; Mian C; Filetti S; Durante C; Fugazzola L
    Thyroid; 2023 Nov; 33(11):1318-1326. PubMed ID: 37725571
    [No Abstract]    [Full Text] [Related]  

  • 15. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
    Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
    BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas.
    Napoli N; Kauffmann EF; Ginesini M; Lami L; Lombardo C; Vistoli F; Campani D; Boggi U
    Updates Surg; 2023 Sep; 75(6):1481-1496. PubMed ID: 37535191
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The holistic management of malignant bowel obstruction in women with advanced ovarian cancer at end of life.
    Gaughan S; Williams M
    Br J Nurs; 2023 Jun; 32(12):550-555. PubMed ID: 37344127
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine Tumors and metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
    Gudmundsdottir H; Habermann EB; Vierkant RA; Starlinger P; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Nagorney DM; Cleary SP
    Ann Surg Oncol; 2023 Aug; 30(8):4840-4851. PubMed ID: 37208566
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
    Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
    Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.